Cas no 1204745-88-9 ((3,4-bis(trifluoromethyl)phenyl)boronic acid)

(3,4-Bis(trifluoromethyl)phenyl)boronic acid is a versatile boronic acid derivative widely employed in Suzuki-Miyaura cross-coupling reactions, a key methodology for forming carbon-carbon bonds in organic synthesis. The presence of two trifluoromethyl groups enhances its electron-withdrawing properties, improving reactivity in palladium-catalyzed transformations. This compound exhibits good stability under standard conditions and is soluble in common organic solvents, facilitating its use in diverse reaction setups. Its structural features make it particularly valuable in pharmaceutical and materials science research, where precise functionalization of aromatic systems is required. The high purity and consistent performance of (3,4-bis(trifluoromethyl)phenyl)boronic acid ensure reliable results in demanding synthetic applications.
(3,4-bis(trifluoromethyl)phenyl)boronic acid structure
1204745-88-9 structure
Product Name:(3,4-bis(trifluoromethyl)phenyl)boronic acid
CAS No:1204745-88-9
MF:C8H5BF6O2
MW:257.925523519516
MDL:MFCD11617946
CID:889674
PubChem ID:52982881
Update Time:2025-06-23

(3,4-bis(trifluoromethyl)phenyl)boronic acid Chemical and Physical Properties

Names and Identifiers

    • 3,4-Bis(trifluoromethyl)phenylboronic acid
    • (3,4-bis(trifluoromethyl)phenyl)boronic acid
    • 1204745-88-9
    • [3,4-bis(trifluoromethyl)phenyl]boronic acid
    • SCHEMBL3789433
    • DB-293837
    • 6-Ghydroxy-2-aAzaspiro[3.3]heptane-2-carboxylic Acid 1,1-Dimethylethyl Ester
    • DTXSID10680690
    • GIZQTQOXIWPFOA-UHFFFAOYSA-N
    • tert-?Butyl 6-?Hydroxy-?2-?azaspiro[3.3]?heptane-?2-?carboxylate
    • 3,4-Bis(trifluoromethyl)phenylboronicacid
    • AKOS015919947
    • AS-30579
    • 3,4-Bis(trifluoromethyl) phenylboronic acid, 96%
    • MFCD11617946
    • 3,4-Bis(trifluoromethyl) Phenylboronic acid
    • MDL: MFCD11617946
    • Inchi: 1S/C8H5BF6O2/c10-7(11,12)5-2-1-4(9(16)17)3-6(5)8(13,14)15/h1-3,16-17H
    • InChI Key: GIZQTQOXIWPFOA-UHFFFAOYSA-N
    • SMILES: FC(C1C=C(B(O)O)C=CC=1C(F)(F)F)(F)F

Computed Properties

  • Exact Mass: 258.02900
  • Monoisotopic Mass: 258.0286785g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 17
  • Rotatable Bond Count: 3
  • Complexity: 264
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 40.5?2

Experimental Properties

  • PSA: 40.46000
  • LogP: 1.40400

(3,4-bis(trifluoromethyl)phenyl)boronic acid Customs Data

  • HS CODE:2931900090
  • Customs Data:

    China Customs Code:

    2931900090

    Overview:

    2931900090. Other organic-Inorganic compound. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:AB(Customs clearance form for Inbound Goods,Customs clearance form for outbound goods). MFN tariff:6.5%. general tariff:30.0%

    Summary:

    2931900090. other organo-inorganic compounds. VAT:17.0%. Tax rebate rate:13.0%. Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward). MFN tariff:6.5%. General tariff:30.0%

(3,4-bis(trifluoromethyl)phenyl)boronic acid Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
NAN JING YAO SHI KE JI GU FEN Co., Ltd.
PBEB0434-1 G
(3,4-bis(trifluoromethyl)phenyl)boronic acid
1204745-88-9 95%
1g
¥ 1,399.00 2021-05-07
NAN JING YAO SHI KE JI GU FEN Co., Ltd.
PBEB0434-5 G
(3,4-bis(trifluoromethyl)phenyl)boronic acid
1204745-88-9 95%
5g
¥ 4,204.00 2021-05-07
NAN JING YAO SHI KE JI GU FEN Co., Ltd.
PBEB0434-10 G
(3,4-bis(trifluoromethyl)phenyl)boronic acid
1204745-88-9 95%
10g
¥ 7,009.00 2021-05-07
Alichem
A242000570-250mg
3,4-Bis(trifluoromethyl)phenylboronic acid
1204745-88-9 98%
250mg
$748.00 2023-09-04
Alichem
A242000570-500mg
3,4-Bis(trifluoromethyl)phenylboronic acid
1204745-88-9 98%
500mg
$989.80 2023-09-04
Alichem
A242000570-1g
3,4-Bis(trifluoromethyl)phenylboronic acid
1204745-88-9 98%
1g
$1617.60 2023-09-04
Chemenu
CM136420-1g
3,4-Bis(trifluoromethyl)phenylboronic acid
1204745-88-9 95+%
1g
$139 2021-08-05
Chemenu
CM136420-5g
3,4-Bis(trifluoromethyl)phenylboronic acid
1204745-88-9 95+%
5g
$466 2021-08-05
Chemenu
CM136420-10g
3,4-Bis(trifluoromethyl)phenylboronic acid
1204745-88-9 95+%
10g
$746 2021-08-05
TRC
B412865-100mg
3,4-Bis(trifluoromethyl) Phenylboronic Acid
1204745-88-9
100mg
$ 64.00 2023-04-18

Additional information on (3,4-bis(trifluoromethyl)phenyl)boronic acid

Recent Advances in the Application of (3,4-bis(trifluoromethyl)phenyl)boronic Acid (CAS: 1204745-88-9) in Chemical Biology and Pharmaceutical Research

In recent years, (3,4-bis(trifluoromethyl)phenyl)boronic acid (CAS: 1204745-88-9) has emerged as a pivotal compound in chemical biology and pharmaceutical research due to its unique physicochemical properties and versatile reactivity. This boronic acid derivative, characterized by its trifluoromethyl substituents, has been extensively studied for its applications in drug discovery, bioconjugation, and materials science. The compound's ability to form reversible covalent bonds with diols and other nucleophiles makes it particularly valuable in the development of targeted therapeutics and diagnostic tools. This research brief synthesizes the latest findings on this compound, highlighting its mechanistic insights, synthetic utility, and potential clinical applications.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficacy of (3,4-bis(trifluoromethyl)phenyl)boronic acid as a key intermediate in the synthesis of novel proteasome inhibitors. The researchers utilized its boronic acid moiety to form stable tetrahedral adducts with the catalytic threonine residues of the 20S proteasome, achieving nanomolar inhibitory activity. This work underscores the compound's role in addressing drug resistance in multiple myeloma and other malignancies. The study also reported improved pharmacokinetic profiles of derivatives incorporating this boronic acid, suggesting enhanced bioavailability compared to earlier generations of proteasome inhibitors.

In the realm of chemical biology, recent advancements have exploited the compound's fluorinated aromatic system for 19F NMR applications. A Nature Chemical Biology publication (2024) detailed its incorporation into activity-based probes for real-time monitoring of glycosidase enzymes. The electron-withdrawing trifluoromethyl groups significantly enhanced the sensitivity of 19F NMR detection, enabling researchers to track enzymatic activity in complex biological matrices with unprecedented resolution. This methodological breakthrough opens new avenues for studying carbohydrate metabolism and developing glycosidase-targeted therapies.

The compound's utility in materials science has also seen significant progress. A 2024 ACS Applied Materials & Interfaces report highlighted its role as a building block for self-assembled monolayers (SAMs) on gold surfaces. The boronic acid functionality facilitated the formation of stable, ordered monolayers, while the trifluoromethyl groups imparted exceptional hydrophobicity and chemical resistance. These properties make the resulting SAMs particularly suitable for biosensor applications where stability in aqueous environments is crucial. The study demonstrated successful glucose detection using these modified surfaces, with potential implications for continuous glucose monitoring systems.

From a synthetic chemistry perspective, recent work has focused on developing more efficient routes to (3,4-bis(trifluoromethyl)phenyl)boronic acid. A 2023 Organic Process Research & Development article described a novel continuous flow synthesis method that improved yield (82%) and purity (>99%) while reducing hazardous waste generation. This advancement addresses previous challenges in scaling up production, making the compound more accessible for industrial applications. The optimized synthetic route also enabled the preparation of deuterated and 13C-labeled analogs for mechanistic studies and tracer applications.

Looking forward, the unique properties of (3,4-bis(trifluoromethyl)phenyl)boronic acid position it as a promising candidate for several emerging applications. Current preclinical studies are investigating its potential in boron neutron capture therapy (BNCT), leveraging both the boron atom and the electron-deficient aromatic system for dual therapeutic effects. Additionally, its application in covalent inhibitor design continues to expand, with recent computational studies predicting favorable interactions with previously undruggable targets. As research progresses, this compound is expected to play an increasingly important role at the interface of chemistry, biology, and medicine.

Recommended suppliers
Shanghai Jinhuan Chemical CO., LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Jinhuan Chemical CO., LTD.
SHOCHEM(SHANGHAI) CO.,lTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
SHOCHEM(SHANGHAI) CO.,lTD
Shenzhen GeneSeqTools Bioscience & Technology Co. Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shenzhen GeneSeqTools Bioscience & Technology Co. Ltd.
上海帛亦醫(yī)藥科技有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd